๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effects of kappa receptor agonists on D1and D2dopamine agonist and antagonist-induced behaviors

โœ Scribed by C. Marin; T. M. Engber; P. Chaudhuri; A. Peppe; T. N. Chase

Publisher
Springer
Year
1996
Tongue
English
Weight
977 KB
Volume
123
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Selectivity of agonists and antagonists
Selectivity of agonists and antagonists at D2dopamine receptors compared to D1 and S2receptors
โœ Dr. Philip Seeman; Dimitri E. Grigoriadis; Hyman B. Niznik ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 332 KB

Seeman, P., D.E. Grigoriadis, and H.B. Niznik: Selectivity of agonists and antagonists at D2 dopamine receptors compared to D, and S2 receptors. Drug Dev. Res. 9:63-69, ## 1986. The common dopamine agonists (dopamine, apomorphine, ADTN, and N-propylnorapomorphine) are not selective for either D,

Effect of the putative dopamine D1 agoni
Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
โœ L. Verhagen Metman; P. J. Blanchet; D. de Jong; M. M. Mouradian; Dr. T. N. Chase ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 433 KB

## Abstract The ergoline derivative FCE 23884 acts as a dopamine D~1~ agonist in untreated parkinsonian animals and as a D~2~ antagonist in animals whose dopamine system is intact or levodopa treated. To evaluate whether this dual action might benefit patients with Parkinson's disease (PD) who have